Milestone in Urological Surgery
Andromeda Surgical announced the successful completion of the world’s first robotic-assisted holmium laser enucleation of the prostate (HoLEP) procedure using its robotic platform. The landmark procedure was performed in Chile by Dr. Cristián Trucco of Universidad Católica via a tablet interface as part of the ASTRA clinical trial.
Revolutionizing Prostate Surgery
Designed for seamless integration with existing surgical tools, Andromeda’s endoscopic robotic platform enhances surgeon control and efficiency during transurethral procedures. Its mission is to enable urologists to perform HoLEP at an expert level, providing effective treatment for benign prostatic hyperplasia (BPH).
Key highlights include:
- Tablet interface: Simplifies control, marking a first in surgical robotics.
- Expert-level capabilities: Reduces learning curves, broadening access to high-quality care.
Rapid Innovation Timeline
Founded in 2023, Andromeda transitioned its platform from concept to clinical use in just 18 months. Next steps include:
- Expanding system capabilities for additional indications.
- Integrating autonomous features to enhance precision and reduce variability.
Looking Ahead
The ASTRA trial will continue enrolling patients in Chile, with expansion to New Zealand planned for early 2025.
CEO Nick Damiano expressed optimism:
“This milestone is the first step towards giving every patient access to the best possible surgical outcomes. Seeing our work translate into real-world benefits is incredibly rewarding.”
Follow MEDWIRE.AI for updates on transformative innovations in robotic surgery and urological care.
